ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

FBLG FibroBiologics Inc

9.75
1.01 (11.56%)
May 10 2024 - Closed
Delayed by 15 minutes

FibroBiologics Financial Summary

The current FBLG market cap is 318.19M. The company's latest EPS is USD -0.5840 and P/E is -15.75.

Quarter End Sep 2023Dec 2023
USD ($)USD ($)
Total Revenue 00
Operating Income -2.05M-2.48M
Net Income -2.19M-12.29M
Year End December 30 2023 20222023
USD ($)USD ($)
Total Revenue 00
Operating Income -4.47M-8.89M
Net Income -5.12M-19.06M
Quarter End Sep 2023Dec 2023
USD ($)USD ($)
Total Assets 13.3M11.82M
Total Liabilities 2.76M10.57M
Total Equity 10.54M1.25M
Year End December 30 2023 20222023
USD ($)USD ($)
Total Assets 4.82M11.82M
Total Liabilities 8.82M10.57M
Total Equity -4M1.25M
Quarter End Sep 2023Dec 2023
USD ($)USD ($)
Operating -4.8M-6.4M
Investing -493k-495k
Financing 13.79M13.79M
Year End December 30 2023 20222023
USD ($)USD ($)
Operating -4.07M-6.4M
Investing N/A -495k
Financing 5.93M13.79M
Market Cap 318.19M
Price to Earnings Ratio -15.75
Price to Sales Ratio 0
Price to Cash Ratio 32.76
Price to Book Ratio 239.61
Dividend Yield -

Share Statistics

Shares Outstanding 32.63M
Average Volume (1 week) 47.97k
Average Volume (1 Month) 67.49k
52 Week Change -67.50%
52 Week High 55.00
52 Week Low 6.53
Spread (Intraday) 1.07 (10.9%)

Company Info

Company Name FibroBiologics Inc
Address corporation trust center
wilmington, delaware 19801
Website https://www.fibrobiologics.com
Industry pharmaceutical preparations (2834)